Form 4: BioDeisx Director Jack Schuler Acquires 100,000 Shares

Director Jack Schuler of BioDeisx Inc. purchased 100,000 shares of common stock at a weighted average price of $1.2284 per share.

Summary

• Jack Schuler, a director and 10% owner of BioDeisx Inc., acquired 100,000 shares of common stock on November 21, 2024.
• The shares were purchased at a weighted average price of $1.2284 per share, with individual transaction prices ranging from $1.225 to $1.23.
• The purchase was made indirectly through the Jack W. Schuler Living Trust, of which Jack W. Schuler is the sole trustee.
• Following this transaction, the Jack W. Schuler Living Trust beneficially owns 31,194,935 shares of BioDeisx Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive as a director purchasing shares can be seen as a sign of confidence, but it's a routine transaction.

Positives

• A director's purchase of shares can be seen as a positive signal of confidence in the company's future prospects.

Industry Context

This transaction is a routine disclosure of insider trading activity and does not indicate any specific industry trend.

Comparison to Industry Standards

• Insider trading activity is a common occurrence in publicly traded companies, and this transaction is within the normal range of such activities.
• It is common for directors and officers to purchase shares of their own company, and this transaction is not unusual in that context.
• The size of the transaction, 100,000 shares, is not particularly large compared to other insider transactions.

Stakeholder Impact

• The purchase may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

BioDeisx, insider trading, share purchase, director, Jack Schuler, common stock, beneficial ownership